Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06001801 · ClinicalTrials.gov registry record · NA
The Inspiring Action to Prevent Diabetes Intervention
A NA study of PreDiabetes, sponsored by University of Michigan.
- Active
- Registry status
- NA
- Development phase
- 142
- Enrollment target
- 1
- Study location
NCT06001801: Active NA study of PreDiabetes, sponsored by University of Michigan.
NCT06001801 is a NA study of PreDiabetes that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 142 participants, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06001801, a NA study of PreDiabetes, is active but no longer recruiting, sponsored by University of Michigan.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 142 participants
- Enrollment target
- 1
- Study location
Study Summary
This research is studying how to help increase uptake of and engagement in formal Diabetes Prevention Programs to improve healthy behaviors among adults with pre diabetes to reduce risk of getting diabetes. This project will compare the Diabetes Prevention Program (DPP) to participating in the DPP program plus two extra pieces (INSPIRA). The 2 additional pieces in the DPP plus program includes getting matched with someone else in the program to provide each other support along with a chance to earn healthy food vouchers. Eligible participants will be randomized to one of the two groups and be asked to participate for approximately 6 months.
Primary Outcome
This count will be out of 16 possible weekly group sessions.
Conditions Studied
Interventions
- BEHAVIORAL Diabetes Prevention Program
- BEHAVIORAL INSPIRA
Study Locations (1)
Michigan
- Community Health and Social Services Center, Incorporated - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2023-09-18 |
| Est. Completion | 2025-12 |
| Phase | NA |
What the registry record for NCT06001801 still lists
NCT06001801 is an interventional study that assigns participants to a tested intervention. The registered 142 participants enrollment target is mid-sized for trials with a published cap, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (80% lower).
The record links to 1 condition, with PreDiabetes appearing as the primary indexed condition, and to 2 interventions - of which Diabetes Prevention Program is the first listed.
NCT06001801 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06001801 about?
NCT06001801 is a clinical study titled "The Inspiring Action to Prevent Diabetes Intervention". This research is studying how to help increase uptake of and engagement in formal Diabetes Prevention Programs to improve healthy behaviors among adults with pre diabetes to reduce risk of getting diabetes. This project will compare the Diabetes Prevention Program (DPP) to participating in the DPP ...
What is the current status of trial NCT06001801?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 142 participants. The study started on 2023-09-18. Estimated completion is 2025-12.
What conditions does trial NCT06001801 study?
This clinical trial studies the following conditions: PreDiabetes.
What interventions are being tested in trial NCT06001801?
The interventions under investigation include: Diabetes Prevention Program (BEHAVIORAL), INSPIRA (BEHAVIORAL).
Who is sponsoring clinical trial NCT06001801?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06001801 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PreDiabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06001801's enrollment target sits among peer trials
142 52nd of 149 higher than 98 of 149 other PreDiabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
-
Cleaner Air for Lower Cardiometabolic Risk
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03933631 · 142 participants · Phase 3
Pilocarpine Use After Kahook Goniotomy
- NCT04938349 · 142 participants · NA
Dual Task Perturbation Training for OAwMCI
- NCT06117254 · 142 participants · NA
Hearing Aids for Veterans With Functional Hearing Difficulties
- NCT06463665 · 142 participants · Phase 2
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI